Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 30776053.
- Also identified by DOI 10.1001/jamainternmed.2018.7656 and PMC identifier 6503568.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses wholesale medication acquisition costs and Medicare claims data to assess how prices of existing tumor necrosis factor inhibitors changed in response to the market entry of new tumor necrosis factor inhibitors.
Medical subject headings
- Costs and Cost Analysis
- Drug Industry
- Tumor Necrosis Factor Inhibitors